Canadian Cardiovascular Society

Hypertrophic Cardiomyopathy Learning Series

Welcome to the Hypertrophic Cardiomyopathy Learning Series

The original Hypertrophic Cardiomyopathy Learning Series launched in 2022 as a six-part multipronged and multimodal program, including three MOC Section 1 accredited webinars and three MOC Section 3 accredited programs.

This educational series is designed to support learning and to refine the knowledge and skills of specialists and primary care providers on topics related to Hypertrophic Cardiomyopathy.

Program Chairs:

Dr. Michael Chetrit
Dr. Gillian Nesbitt

Past Events:

Part 1: HCM in Everyday Practice
Date: May 26, 2022 from 8:00 p.m. to 9:00 p.m. EDT
Faculty: Dr. Andrew Frost, Dr. Anil Gupta, Dr. Jacqueline Joza, and Dr. Benedicte Lefebvre


Part 2: Risk Stratification in Hypertrophic CMP
Date: September 7, 2022 from 8:00 p.m. to 9:00 p.m. EDT
Faculty: Dr. Haya Aziz, Dr. Andreas Kumar, Dr. Zachery Laksman, and Dr. Yang Zhan


Part 3: Therapeutics in HCM
Date: October 28, 2022 from 12:30 p.m. to 1:30 p.m. EDT (Accredited Symposia at CCC 2022)
Faculty: Dr. Haya Aziz, Dr. Andreas Kumar, Dr. Zachery Laksman, and Dr. Yang Zhan


This session has received an educational grant from Bristol Myers Squibb Canada. This program was developed by the Canadian Cardiovascular Society and was planned to achieve scientific integrity, objectivity, and balance.

 

Back to top